Search - tctmd.com

Displaying 1 - 20 of 93

Sort: Relevancy | Date

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Features

Year in Review: Women’s Heart Health in the Spotlight

Caitlin E. Cox

December 23, 2025

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Yael L. Maxwell

October 24, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

AI-Supported Coaching Shows Promise for Improving Glycemic Control

L.A. McKeown

August 25, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

Todd Neale

July 14, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Daily News

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

Todd Neale

January 09, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome

Caitlin E. Cox

October 04, 2024

News Daily News

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

Todd Neale

August 15, 2024

News Daily News

Improved Lipids With Gastric Bypass Linked to Surgery Itself, Not Weight Loss

Michael O'Riordan

July 23, 2024

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

News Daily News

How Mediterranean Diets Might Cut Mortality in Women: New Insights

Yael L. Maxwell

June 05, 2024

Advertisement

Heart Disease Remains Number One Killer of Americans

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Year in Review: Women’s Heart Health in the Spotlight

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Risk Factors Present in Nearly All Patients Who Develop CVD

CVD Still the Leading Cause of Death and Disease Globally

AI-Supported Coaching Shows Promise for Improving Glycemic Control

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

Top General Cardiology and Prevention News of 2024

December 2024 Dispatch for the CV Team

Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

Improved Lipids With Gastric Bypass Linked to Surgery Itself, Not Weight Loss

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

How Mediterranean Diets Might Cut Mortality in Women: New Insights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content